Written by : Dr. Aishwarya Sarthe
March 25, 2025
The funding will support the expansion of DCDC’s dialysis network across India, aiming to improve accessibility for patients with ESRD.
DCDC Health Services, operating under the DCDC Kidney Care brand, has received an investment of INR 150 Cr from Singapore-based ABC Impact, a Temasek-backed impact investor.
The funding will support the expansion of DCDC’s dialysis network across India, aiming to improve accessibility for patients with end-stage renal disease (ESRD).
Aseem Garg, Founder and CEO of DCDC, said, "This investment from ABC Impact will help enhance our efforts to transform kidney care in India. With this investment, we plan to expand our network of company-owned centers, ensuring last-mile connectivity and making high-quality dialysis care accessible closer to patients’ homes. We also plan to address this challenge and extend our solutions to countries beyond India."
DCDC Kidney Care, established in 2009, runs over 200 dialysis centers nationwide, providing services through public-private partnerships (PPP) and company-owned clinics.
With the latest investment, the Delhi-based healthcare provider plans to launch 150 additional centers in the coming months. The move is expected to reduce travel distances for dialysis patients, many of whom travel up to 50 kilometers for treatment.
India has an estimated 1.5 million ESRD patients, requiring thrice-weekly dialysis sessions. However, high costs, limited availability, and inconsistent quality of care remain significant challenges, particularly for low-income families. Many patients are forced to discontinue treatment due to financial constraints, making expanded dialysis access a critical need.
Sugandhi Matta, Chief Impact Officer at ABC Impact, emphasized the investment's healthcare and economic significance, saying, "With the growing burden of kidney disease in India, increasing access to quality dialysis is both a healthcare and economic necessity. DCDC’s proven model of expanding affordable dialysis services aligns with our commitment to improving healthcare outcomes while ensuring long-term sustainability. By supporting DCDC’s growth, we aim to help more patients receive life-saving treatment closer to home, reducing their current financial and logistical barriers."
DCDC Kidney Care’s existing investors include IFU (Investment Fund for Developing Countries), a Danish government-owned investment fund, and the Asian Development Bank (ADB). IFU's participation is through the Danish SDG Investment Fund, which is supported by the Danish State, private institutions, and pension funds.